Department of Oncology and Dendritic Cell Therapy
The Department of Oncology and Dendritic Cell Therapy specializes in the treatment of various types of cancer. The key focus of the work of the department's doctors is advanced LANEX-DC® dendritic cell immunotherapy. Today, the medical facility is one of the world's leading providers of dendritic cell therapy. The department most often admits patients with skin, breast, prostate, pancreatic, kidney, colon, ovarian, etc. cancers. Prior to starting treatment, a patient undergoes comprehensive diagnostics, based on the results of which doctors determine the advisability of cell therapy. Dendritic cell immunotherapy is indicated for patients with advanced cancer who are not responding to standard treatment with chemotherapy, radiation therapy, and other classical methods. Treatment is carried out on an outpatient basis. More than 2,500 LANEX-DC® immunotherapy procedures have been successfully performed in the department, which contributes to the high credibility of the medical facility in this area. The department regularly admits many patients from abroad who want to undergo innovative treatment that is not available in their native country.